-->

Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 22, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 15, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 13, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 6, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 5, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 5, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 2, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 2, 2008View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionMay 1, 2008View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventApr 29, 2008View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesApr 29, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 22, 2008View HTMLDownload DOCDownload PDF
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Apr 9, 2008View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesApr 4, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 4, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 3, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 2, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 2, 2008View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-150      151-152

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information